How can you track nutrition when appetite signals become unreliable
"People can lose more fat." Retatrutide: Next-gen obesity drug helps patients lose 28% of body weight In a phase-three trial by Eli Lilly, patients on the highest dose lost an average of 28.3% of their body weight over a year and a half, and more than 45% of participants lost at least 30%, a level of efficacy the company said approaches results seen with bariatric surgery
Potent One of the most powerful cognitive enhancement compounds available, with effects on synaptic formation surpassing traditional nootropics Studied Extensively researched for cognitive enhancement, neuroplasticity promotion, and neurological support with documented efficacy in preclinical models Questions Dihexa operates through a fundamentally different mechanism compared to traditional nootropics like racetams, cholinergics, or stimulants
If youve been following health news lately, youve probably heard about the buzz surrounding new weight loss medications
At my own weight loss practice seeing patients at Bariendo, I do occasionally prescribe GLP1 medications within certain parameters
Protocol 2: the tirzepatide micro-step escalation Goal: Avoid the dramatic side effects common with standard 2.5 mg escalation jumps Schedule (compounded tirzepatide required): Weeks 1-4: 2.5 mg weekly Weeks 5-8: 3.0 mg weekly Weeks 9-12: 3.75 mg weekly Weeks 13-16: 5.0 mg weekly Weeks 17-20: 6.25 mg weekly Weeks 21-24: 7.5 mg weekly Continue escalating by 1.25-2.5 mg every 4 weeks as needed Why the plotter supports this: The standard jump from 2.5 mg to 5 mg produces a transition spike where your first-week peak at 5 mg can exceed the eventual 5 mg steady-state peak by 15-25%
